• Here are the top 10 ASX 200 shares today

    3 children standing on podiums wearing Olympic medals.

    It was a lacklustre finish to what has been a rather rough trading week for the S&P/ASX 200 Index (ASX: XJO) this Friday.

    After a shaky and volatile session that saw the index whipsaw quite a lot, the ASX 200 ended up closing 0.078% lower by the time the markets closed up shop. That leaves the index at 8,786.5 points as we head into the weekend.

    This inglorious end to the trading week for ASX investors follows a red night up on Wall Street.

    The Dow Jones Industrial Average Index (DJX: .DJI) wasn’t in a good mood, shedding 0.36%.

    The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) fared worse, though, dropping by 0.89%.

    But let’s return to the local markets now and see how the various ASX sectors ended their respective weeks today.

    Winners and losers

    Despite the broader market’s drop, we still saw a few sectors make gains. But first, let’s check out the losers.

    Leading that sorry group today were gold stocks. The All Ordinaries Gold Index (ASX: XGD) had a clanger, cratering by 2.51%.

    Broader mining shares weren’t that much better, with the S&P/ASX 200 Materials Index (ASX: XMJ) plunging 1.01%.

    Industrial stocks were far tamer, though. The S&P/ASX 200 Industrials Index (ASX: XNJ) ended up retreating by 0.32%.

    Real estate investment trusts (REITs) were in exactly the same boat, as you can see by the S&P/ASX 200 A-REIT Index (ASX: XPJ)’s 0.32% dive.

    Tech shares followed close behind that. The S&P/ASX 200 Information Technology Index (ASX: XIJ) saw its value dip by 0.28% this Friday.

    Our last losers this Friday were consumer discretionary stocks, with the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) slipping 0.03% lower.

    Turning to the winners now, it was utilities shares that fronted the pack. The S&P/ASX 200 Utilities Index (ASX: XUJ) saw its value soar by 2.17% today.

    Energy stocks also ran hot, evidenced by the S&P/ASX 200 Energy Index (ASX: XEJ)’s 1.47% surge.

    Consumer staples shares proved to be a safe haven, too. The S&P/ASX 200 Consumer Staples Index (ASX: XSJ) jumped by 0.38% this session.

    Financial stocks were in the same ballpark, with the S&P/ASX 200 Financials Index (ASX: XFJ) bouncing 0.3%.

    Communications shares didn’t miss out. The S&P/ASX 200 Communication Services Index (ASX: XTJ) lifted 0.23% today.

    Finally, healthcare stocks got across the line, as illustrated by the S&P/ASX 200 Healthcare Index (ASX: XHJ)’s 0.18% rise.

    Top 10 ASX 200 shares countdown

    Today’s index winner was tech stock Data#3 Ltd (ASX: DTL). This company’s shares vaulted 5.81% higher over today’s trading to finish at $8.01 each.

    That’s despite an absence of any news from Data #3, though

    Here’s the rest of today’s best:

    ASX-listed company Share price Price change
    Data#3 Ltd (ASX: DTL) $8.01 5.81%
    Suncorp Group Ltd (ASX: SUN) $17.05 4.47%
    Austal Ltd (ASX: ASB) $4.62 4.29%
    Endeavour Group Ltd (ASX: EDV) $3.50 3.55%
    Reliance Worldwide Corporation Ltd (ASX: RWC) $3.05 3.39%
    Telix Pharmaceuticals Ltd (ASX: TLX) $14.90 3.26%
    Vulcan Energy Resources Ltd (ASX: VUL) $3.65 3.11%
    AGL Energy Ltd (ASX: AGL) $9.53 2.92%
    Woodside Energy Group Ltd (ASX: WDS) $32.61 2.64%
    Origin Energy Ltd (ASX: ORG) $12.77 2.57%

    Enjoy the weekend!

    Our top 10 shares countdown is a recurring end-of-day summary that shows which companies made big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

    The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Data#3 and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 ASX 200 stocks that could rise 50%

    Person pointing at an increasing blue graph which represents a rising share price.

    If you are looking for some big potential returns for your investment portfolio, then it could pay to hear what Morgans is saying about the two ASX 200 shares in this article.

    That’s because the broker believes these shares are cheap and have the potential to rise around 50% from where they trade today.

    Let’s see what the broker is recommending to clients this week:

    Collins Foods Ltd (ASX: CKF)

    Morgans thinks this quick service restaurant operator’s shares are undervalued at current levels.

    The broker has a buy rating and $12.50 price target on its shares. Based on its current share price of $8.29, this implies potential upside of 50%.

    Commenting on its buy recommendation, Morgans said:

    We revise our CKF forecasts ahead of the FY26 result in June, trimming underlying NPAT to reflect deferred store openings, reset German acquired store economics, and a lower EU SSS assumption to better capture the Netherlands-skewed mix for FY26, partially offset by a marginal AU SSS upgrade on sustained KFC Australia momentum. We maintain our BUY recommendation and reduce our price target to $12.50 (from $12.70).

    Pro Medicus Ltd (ASX: PME)

    Another ASX 200 share that Morgans is recommending to clients is health imaging technology company Pro Medicus.

    After making adjustments to its financial model for Pro Medicus, the broker has retained its buy rating with a $210.00 price target. Based on its current share price of $138.73, this implies potential upside of 51% for investors between now and this time next year.

    Morgans has been impressed with Pro Medicus’ contract wins since the release of its half-year results in February and remains very positive on its long-term growth opportunity. It explains:

    In this note, we deploy a new PME model where we have deliberately set a lower bar. Our remodelled estimates prioritise achievability over optimism, staging implementation revenue conservatively and mark FX to spot. We see this as the right framework for a stock where sentiment has been fragile. On the business operations front, the story remains untarnished.

    Contract newsflow since February has been exceptional: ~$100m in wins and renewals, all at higher pricing, with cardiology upsell gaining traction. The demand story is not in question. We re-emphasise our positive long-term conviction on the name although lower our valuation to reflect current but potentially fleeting headwinds. Our target price is reduced to A$210 p/s and we retain our Buy recommendation.

    The post 2 ASX 200 stocks that could rise 50% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Collins Foods Limited right now?

    Before you buy Collins Foods Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Collins Foods Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Collins Foods and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Collins Foods and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • I was going to buy these ASX tech stocks. Now, I’m not so sure

    A financial expert or broker looks worried as he checks out a graph showing market volatility.

    Back in January, I wrote a piece that named two ASX tech stocks as the top of my buy list if the share market experienced a crash in 2026.

    Those two ASX tech stocks were TechnologyOne Ltd (ASX: TNE) and Pro Medicus Ltd (ASX: PME). These companies are two of Australia’s finest. Both have consistently delivered for shareholders over recent years and boast enviable stock price trajectories.

    At the time, I outlined my view that if these companies descended to a price point that indicated significant potential value, then I would be tempted to load the boat.

    However, I must confess that my faith has been shaken.

    As I’ve already touched on, both of these companies are proven winners. TechnologyOne prides itself on its enterprise software products, which have proven wildly popular with governments and businesses in Australia and overseas.

    Pro Medicus is also in the software space. Its medical imaging services are in high demand worldwide.

    Both companies continue to report happy numbers.

    For example, in February, Pro Medicus delivered a 29.7% surge in underlying profits for the six months to 31 December 2025 to $90.7 million.

    What’s got me sour on these two ASX tech stocks?

    So why the loss of faith? Well, it’s to do with artificial intelligence (AI). Yes, we’ve known about the potential upsides, as well as the potential disruption, of AI technology for a while now. That said, it has recently become clearer that enterprise software stocks face a particularly high level of disruptive risk from AI.

    Now, I am no AI expert. But I do see the potential for disruption here. AI tools are becoming better and better at solving enterprise problems that (expensive) software currently handles. Anecdotally, I have already heard several stories of AI rendering business software subscriptions redundant.

    There’s every chance that TechnologyOne and Pro Medicus will be able to stay ahead of the curve and evolve and adapt to the threats of AI. But I am not certain of that, not enough to bet my dollars on it anyway.

    Warren Buffett once said that “I don’t look to jump over seven-foot bars, I look around for one-foot bars that I can step over”. These two ASX tech stocks are looking increasingly tall in this modern age of AI, at least in my eyes. As such, I’ll probably stick to shorter stocks to step over, at least for now.

    The post I was going to buy these ASX tech stocks. Now, I’m not so sure appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Pro Medicus right now?

    Before you buy Pro Medicus shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pro Medicus wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Brokers name 3 ASX shares to buy right now

    Contented looking man leans back in his chair at his desk and smiles.

    It has been another busy week for many of Australia’s top brokers. This has led to a number of broker notes being released.

    Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone right now:

    DroneShield Ltd (ASX: DRO)

    According to a note out of Bell Potter, its analysts have retained their buy rating and $4.80 price target on this counter-drone technology company’s shares. This follows the release of a strong first-quarter update which revealed revenue up 121% on the prior corresponding period. Bell Potter was also pleased to see that SaaS revenue continues to grow strongly and now represents 6.9% of revenue. Looking ahead, the broker believes DroneShield has a market leading offering and a strengthening competitive advantage. This leaves it well-placed ahead of an expected wave of spending on these types of solutions. As a result, Bell Potter believes DroneShield should see material contracts flowing from its $2 billion+ potential sales pipeline over the next three to six months. The DroneShield share price is trading at $3.73 on Friday.

    Generation Development Group Ltd (ASX: GDG)

    A note out of Morgans reveals that its analysts have retained their buy rating on this diversified financial services company’s shares with a trimmed price target of $6.16. This follows the release of a solid quarterly update earlier this week. Morgans highlights that once again, the Investment Bond business delivered ahead of expectations. However, taking some of the shine off the result was the softer than expected performance from the Evidentia business. And while the latter has caused the broker to trim its earnings forecasts, it remains positive on Generation Development Group. This is largely due to its exposure to structural growth areas, and its strong competitive positioning in these markets. The Generation Development Group share price is fetching $3.54 at the time of writing.

    WiseTech Global Ltd (ASX: WTC)

    Another note out of Morgans reveals that its analysts have retained their buy rating on this logistics solutions technology company’s shares with a reduced price target of $70.40. Morgans has made significant changes to its technology coverage, lowering valuations to reflect higher discount rates and uncertainty over terminal values due to AI disruption. Despite this, the broker remains very positive on WiseTech Global and has named it as one of its key picks in the sector. The WiseTech Global share price is trading at $44.17 on Friday afternoon.

    The post Brokers name 3 ASX shares to buy right now appeared first on The Motley Fool Australia.

    Should you invest $1,000 in DroneShield Limited right now?

    Before you buy DroneShield Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and DroneShield Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • ASX 200 drops again. This is what’s starting to worry investors

    digital screen of Index, Stock, ASX, Ecomony

    The S&P/ASX 200 Index (ASX: XJO) is yet again under pressure on Friday, with weakness across most sectors weighing on the benchmark.

    At the time of writing, the ASX 200 is down 0.53% to 8,746 points. The index briefly traded lower earlier in the session, continuing a softer run into the end of the week.

    This follows several days of choppy trading, with news headlines starting to play a bigger role in short-term sentiment.

    Here’s what is driving the move.

    Oil prices are back in focus

    One of the main factors sitting over the market is the recent rise in oil prices.

    Brent crude has pushed back above US$106 per barrel, holding near recent highs after a sharp rebound over the past week.

    That move has been linked to the ongoing tensions in the Middle East, particularly around supply disruptions and shipping risks.

    Keep in mind, higher oil prices tend to act as a huge headwind for equity markets.

    They feed into inflation expectations and raise concerns around input costs, which can pressure margins across a wide range of sectors.

    And that is showing up in today’s session.

    Selling spreads across the ASX

    The decline is not being driven by a single sector.

    More than half of the ASX sectors are trading lower, with weakness across financials, materials, and consumer-facing businesses.

    Large-cap banks are mixed, with the S&P/ASX 200 Financials Index (ASX: XFJ) down around 0.3%.

    Miners are under pressure, with the S&P/ASX 200 Resources Index (ASX: XRJ) down roughly 0.8% as commodity prices ease.

    Lithium companies have also been weaker, following production updates and ongoing pricing uncertainty.

    There are still pockets of strength, though.

    Energy stocks are outperforming, with the S&P/ASX 200 Energy Index (ASX: XEJ) up around 1.7%, while S&P/ASX 200 Utilities Index (ASX: XUJ) are also higher, gaining roughly 1.6%.

    But unfortunately that has not been enough to offset the wider pullback across the index.

    Recent momentum starts to fade

    Looking at the recent trend, the ASX 200 had been holding up reasonably well through March and early April.

    The benchmark index remains up close to 10% over the past 12 months, supported by gains in large-cap stocks and strong performance from key sectors.

    However, the past week has seen momentum start to shift.

    The index has pulled back from recent highs and is now tracking lower into the end of the week.

    Daily moves have also become more volatile, with buying interest starting to fade.

    The post ASX 200 drops again. This is what’s starting to worry investors appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • NextDC just raised $750 million, here’s why the shares are climbing

    Two IT professionals walk along a wall of mainframes in a data centre discussing various things

    NextDC Ltd (ASX: NXT) shares are edging higher again on Friday.

    The data centre operator rose 1% to $14.87 during afternoon trade, extending a strong run that has seen the tech stock jump 22% over the past month. Over 12 months, NextDC shares are up 36%, comfortably outperforming the S&P/ASX 200 Index (ASX: XJO), which has gained around 13%.

    So what’s behind the latest move?

    Multi-billion dollar funding

    The catalyst is fresh funding – and plenty of it.

    NextDC announced on Friday that it has successfully priced and allocated a $750 million wholesale subordinated notes offer. The deal lifts its pro forma liquidity, including cash and undrawn facilities, to around $6.6 billion. That’s a big number, and investors interested in NextDC shares are paying attention.

    The capital raise forms part of NextDC’s broader $2.2 billion funding plan. It follows on from a recent entitlement offer and a $1.7 billion hybrid securities deal, completing a multi-pronged strategy to secure capital for growth. In simple terms, the company is loading up the balance sheet to fund its next phase.

    Surging demand for data centres

    That matters because NextDC operates in one of the fastest-growing segments of the market. Demand for data centres continues to surge, driven by cloud computing, artificial intelligence, and digital infrastructure needs across Australia and the Asia-Pacific region. To keep up, the company needs scale, and scale requires capital.

    This latest funding round strengthens and diversifies its financing base. The subordinated notes sit below senior debt but above hybrid securities and equity, adding another layer to its capital structure. While the notes won’t be listed on the ASX and are aimed at wholesale investors, they play an important role in improving financial flexibility.

    Record capacity locked in

    The result is a stronger position to execute. With $6.6 billion in available liquidity, NextDC shares now have significant firepower to fund major data centre developments, support expansion projects, and respond to new opportunities as they arise.

    Importantly, this comes at a time when demand is already building. The company has flagged record contracted utilisation across its portfolio, suggesting existing capacity is being filled quickly.

    That creates a clear runway for growth.

    What next for NextDC shares?

    Of course, there are risks for NextDC shares. Large-scale infrastructure projects require significant upfront investment, and returns can take time to materialise. Higher interest rates and funding costs also remain a factor, particularly as the company continues to expand.

    But for now, the market appears focused on the positives.

    Strong demand, a clear growth strategy, and a well-funded balance sheet are combining to support sentiment. Investors are backing NextDC’s ability to execute, and today’s update reinforces that confidence.

    If the company continues to deliver on its expansion plans, this funding boost could prove to be a key catalyst for the next leg of growth.

    The post NextDC just raised $750 million, here’s why the shares are climbing appeared first on The Motley Fool Australia.

    Should you invest $1,000 in NEXTDC Limited right now?

    Before you buy NEXTDC Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and NEXTDC Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 6 ASX 200 shares downgraded by brokers this week

    Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.

    S&P/ASX 200 Index (ASX: XJO) shares are in the red for a fourth consecutive day, down 0.46% to 8,752.8 points.

    The world is waiting for a fresh round of negotiations between the US and Iran to begin, as the global oil shock continues.

    Meanwhile, the International Monetary Fund has warned of a global recession given the long-tail impact of energy supply shocks.

    Amid this ongoing turmoil, brokers have reduced their ratings on six ASX 200 shares this week.

    Let’s take a look.

    Macquarie Group Ltd (ASX: MQG)

    The Macquarie share price is $231.83, up 0.5% today.

    Over the past month, this ASX 200 bank share has lifted substantially, up 19%.

    UBS downgraded Macquarie shares to a hold rating yesterday.

    The broker considers the stock almost fully valued, given its 12-month price target of $235.

    4DMedical Ltd (ASX: 4DX)

    The 4DMedical share price is 7% lower on Friday at $4.91.

    This ASX 200 healthcare share has skyrocketed 1,650% over 12 months.

    Jefferies downgraded 4DMedical shares to a hold rating yesterday.

    However, the broker believes this stock’s value can continue to grow.

    Its 12-month price target is $5.90, implying a potential 17% capital gain ahead.

    QBE Insurance Group Ltd (ASX: QBE)

    The QBE share price is $22.39, up 0.09% today.

    The ASX 200 insurance share has lifted 13% in the year to date (YTD).

    Macquarie downgraded QBE shares to a hold rating with a $25.10 price target on Friday.

    Sandfire Resources Ltd (ASX: SFR)

    The Sandfire Resources share price is $17.26, up 0.2% today.

    The ASX 200 copper share has experienced a remarkable run over the past 12 months, rising 73%.

    The copper commodity price climbed 42% in 2025 due to rising demand amid the green energy transition.

    Sandfire Resources shares reached an all-time high of $21.75 per share in January.

    Copper was sold off alongside other metals in February but has rebounded strongly since mid-March.

    UBS downgraded Sandfire Resources shares to a sell rating today.

    The broker reduced its 12-month price target from $17.70 to $16.75.

    TechnologyOne Ltd (ASX: TNE)

    The TechnologyOne share price is $28.64, down 3.8% today.

    TechnologyOne lost a quarter of its valuation amid the tech wreck that began in 1H FY26.

    The ASX 200 tech share is down 26% over the past six months but has rallied 4.5% this month amid a sector turnaround.

    Morgans downgraded TechnologyOne shares to a hold rating today.

    The broker has a price target of $31.20, implying a potential 9% upside ahead.

    Reece Ltd (ASX: REH)

    The Reece share price is $13.63, up 1% today.

    This ASX 200 industrial share is down 12% year over year, but has lifted 13.6% over the past six months.

    Morgans downgraded Reece shares to a hold rating today.

    The broker reduced its 12-month price target from $17.70 to $14.10.

    This still suggests a near-5% upside ahead.

    The post 6 ASX 200 shares downgraded by brokers this week appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Technology One Limited right now?

    Before you buy Technology One Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Technology One Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Technology One. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 3 ASX 200 stocks storming higher in this week’s sinking market

    three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.

    With just a few hours of trade left in the week, the S&P/ASX 200 Index (ASX: XJO) is down 2.2% since last Friday’s close, despite the best lifting efforts of these three surging ASX 200 stocks.

    One of this week’s top performers provides building materials, one is a global wine maker, and the third earns its keep providing residential aged care.

    Here’s how these ASX shares have managed to charge higher in this week’s sinking market.

    ASX 200 stocks jumping in this week’s sliding market

    First up, we have James Hardie Industries PLC (ASX: JHX).

    Shares in the building materials company closed last Friday at $28.04 and are currently trading at $30.95 apiece. That sees this ASX 200 stock up 10.4% for the week.

    There was no price-sensitive news from James Hardie this week. But after hitting four-month lows of $26.10 a share on 31 March, investors appear to believe the stock has been oversold.

    This brings us to our second outperformer of the week, Treasury Wine Estates Ltd (ASX: TWE) shares.

    Shares in the global wine company closed last week at $4.01 and are currently trading at $4.53 each, putting this ASX 200 stock up 13.0%.

    Treasury Wine shares closed up a whopping 16.5% on Wednesday after the company announced its transition to a new regional operating model.

    Judging by the share price action, investors clearly approved of the move, which is intended to improve operational efficiency for the struggling wine distributor.

    Treasury Wine will transition to its new regional operating model on 1 October. It will then operate four regional divisions: The Americas, Australia and New Zealand (ANZ), Europe, Greater China, and Emerging Markets (Rest of Asia, Middle East and Africa).

    “We are reshaping TWE to drive clearer accountability for performance and to enable faster, more market-connected decision-making as a foundation for consistent depletions growth,” Treasury Wine CEO Sam Fischer said.

    Leading the charge

    Moving on, the top performing ASX 200 stock on my list for this week is Regis Healthcare Ltd (ASX: REG).

    Shares in the residential aged care provider closed last Friday at $5.89 and are currently trading for $6.69 apiece. That puts Regis Healthcare shares up 13.6% in this week’s retreating market.

    Shares in the ASX 200 healthcare stock closed up 16.4% on Thursday.

    While there was no direct price-sensitive news from the company, the Motley Fool’s Cameron England noted that the surge appears to be driven by pending changes to how the Federal government funds residential aged care.

    On Wednesday, health minister Mark Butler announced that the government would spend an additional $3 billion to provide more aged care beds and improve overall care for older Australians.

    The post 3 ASX 200 stocks storming higher in this week’s sinking market appeared first on The Motley Fool Australia.

    Should you invest $1,000 in James Hardie Industries plc right now?

    Before you buy James Hardie Industries plc shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and James Hardie Industries plc wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Treasury Wine Estates. The Motley Fool Australia has positions in and has recommended Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • This ASX biotech stock could deliver 40%-plus returns Morgans says

    Female scientist working in a laboratory.

    Tetratherix Ltd (ASX: TTX) recently updated shareholders with its quarterly report, which broker Morgans says shows the ASX biotech company continues to tick off key milestones towards commercialisation.

    Morgans has this week issued a new research report to its clients, slightly reducing its price target on Tetratherix shares, which we’ll get to later.

    Progress on several fronts

    So what did the company say this week?

    Tetratherix’s key technology is a fluid matrix that can be used in regenerative medicine across multiple applications.

    Chief executive Will Knox said in this week’s statement to the ASX that the third quarter was “another strong quarter for Tetratherix as we continued to deliver against key commercial, clinical and strategic milestones”.

    He added:

    We confirmed readiness to commercialise Tegenix through a global quality and supply agreement with Henry Schein. We also expanded into precision medicine with STEPP, our drug‑delivery platform that has been under stealth development for more than five years. This was folowed by an exclusive R&D agreement with Superpower, under which Tetratherix wil receive licence fees of US$3 milion per year for up to 10 years, together with ongoing purchases of STEPP to support R&D formulation for the US market.

    Mr Knox said the company also advanced multiple clinical programs, with encouraging results across tissue healing, “including positive outcomes from the TetraDerm Cohort 1 and 2 studies, and [the company] accelerated the Tutelix pivotal trial program following the successful Series A capital raise by our joint‑venture partner”.

    The company was also expecting Food & Drug Administration clearance for its bone regeneration technology this calendar year.

    Shares looking cheap

    The analyst team at Morgans agreed it was a strong quarter, “achieving multiple clinical, commercial and operational milestones as it advances toward commercialisation”.

    The broker said:

    Using its innovative Tetramatrix platform technology TTX can develop solutions for multiple medical conditions. TTX is looking to partner with specialist companies to assist with clinical trial, regulatory approvals and market access. We use a discounted cash flow method to value TTX at $6.84. We have set the target price at the same level. We have a speculative buy recommendation on TTX.

    Morgans said the company had multiple catalysts for a share price rerating, although it cautioned that positive clinical trial results were not certain and navigating regulatory pathways can be complex.

    If the share price were to hit Morgans’ price target, it would be a 45.8% return from the current level of $4.69.

    Tetratherix is currently valued at $126.9 million.

    The post This ASX biotech stock could deliver 40%-plus returns Morgans says appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tetratherix right now?

    Before you buy Tetratherix shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tetratherix wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

    Disappointed man with his head on his hand looking at a falling share price his a laptop.

    The S&P/ASX 200 Index (ASX: XJO) is having a poor finish to the week. In afternoon trade, the benchmark index is down 0.5% to 8,751.3 points.

    Four ASX shares that are falling more than most today are listed below. Here’s why they are tumbling:

    Brainchip Holdings Ltd (ASX: BRN)

    The Brainchip share price is down 3% to 15 cents. This follows the release of another disappointing update from the struggling semiconductor company. For the three months ended 31 March, Brainchip recorded customer cash inflows of US$700,000. However, this couldn’t stop the company from recording an operating cash outflow of US$5.3 million for the three months. This led to its cash balance reducing to US$25.3 million from US$31.7 million.

    Fortescue Ltd (ASX: FMG)

    The Fortescue share price is down 5% to $19.93. For the third quarter of FY 2026, Fortescue reported total iron ore shipments of 48.4 million tonnes (Mt). This was below consensus estimates of approximately 49Mt, which may have disappointed investors. Fortescue Metals and Operations CEO, Dino Otranto, was pleased with the quarter. He said: “We delivered a solid quarter, contributing to record shipments of 148.7 million tonnes for the nine months to March. That reflects a significant effort from the team right across the business.” Fortescue also separately announced that it has approved a US$680 million investment to expand its green energy capacity in the Pilbara.

    IGO Ltd (ASX: IGO)

    The IGO share price is down 15% to $7.28. This battery materials company’s shares have been sold off following the release of its quarterly update. Although it posted a 45% increase in group sales revenue to $119.7 million, the market appears disappointed with an update on its guidance. IGO has updated full-year guidance for Greenbushes spodumene production to 1,375kt to 1,425kt (down from 1,500kt to 1,650kt). IGO’s CEO, Ivan van Vella, said: “Fundamental changes to operating approaches and systems take time to be effective and improvements are typically not linear. Greenbushes is a world-class asset and generated 75% EBITDA margin this quarter. I am confident the work underway will deliver the required performance and overall value optimisation.”

    Life360 Inc (ASX: 360)

    The Life360 share price is down 4% to $20.89. This follows another selloff of software stocks on Wall Street overnight. The catalyst for this may have been the release of GPT-5.5 by ChatGPT owner OpenAI. It stated: “We’re releasing GPT‑5.5, our smartest and most intuitive to use model yet, and the next step toward a new way of getting work done on a computer.”

    The post Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Life360 right now?

    Before you buy Life360 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Life360. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.